These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


351 related items for PubMed ID: 7478538

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The transgenic window on lymphoid malignancy.
    Adams JM, Harris AW, Vaux DL, Alexander WS, Rosenbaum H, Klinken SP, Strasser A, Bath ML, McNeall J, Cory S.
    Princess Takamatsu Symp; 1989; 20():297-309. PubMed ID: 2518688
    [Abstract] [Full Text] [Related]

  • 4. Moloney murine leukemia virus infection accelerates lymphomagenesis in E mu-bcl-2 transgenic mice.
    Shinto Y, Morimoto M, Katsumata M, Uchida A, Aozasa K, Okamoto M, Kurosawa T, Ochi T, Greene MI, Tsujimoto Y.
    Oncogene; 1995 Nov 02; 11(9):1729-36. PubMed ID: 7478600
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Loss of Fas/Apo-1 receptor accelerates lymphomagenesis in E mu L-MYC transgenic mice but not in animals infected with MoMuLV.
    Zörnig M, Grzeschiczek A, Kowalski MB, Hartmann KU, Möröy T.
    Oncogene; 1995 Jun 15; 10(12):2397-401. PubMed ID: 7784089
    [Abstract] [Full Text] [Related]

  • 8. The functional basis of c-myc and bcl-2 complementation during multistep lymphomagenesis in vivo.
    Marin MC, Hsu B, Stephens LC, Brisbay S, McDonnell TJ.
    Exp Cell Res; 1995 Apr 15; 217(2):240-7. PubMed ID: 7698223
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Expression of bcl-x during mouse B cell differentiation and following activation by various stimuli.
    Choi MS, Holmann M, Atkins CJ, Klaus GG.
    Eur J Immunol; 1996 Mar 15; 26(3):676-82. PubMed ID: 8605937
    [Abstract] [Full Text] [Related]

  • 11. Growth of E mu-myc transgenic B-lymphoid cells in vitro and their evolution toward autonomy.
    Langdon WY, Harris AW, Cory S.
    Oncogene Res; 1988 Mar 15; 3(3):271-9. PubMed ID: 3144697
    [Abstract] [Full Text] [Related]

  • 12. E mu-bcl-2 transgene facilitates spontaneous transformation of early pre-B and immunoglobulin-secreting cells but not T cells.
    Strasser A, Harris AW, Cory S.
    Oncogene; 1993 Jan 15; 8(1):1-9. PubMed ID: 8423986
    [Abstract] [Full Text] [Related]

  • 13. A non-transgenic mouse model for B-cell lymphoma: in vivo infection of p53-null bone marrow progenitors by a Myc retrovirus is sufficient for tumorigenesis.
    Yu D, Thomas-Tikhonenko A.
    Oncogene; 2002 Mar 14; 21(12):1922-7. PubMed ID: 11896625
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Bcl-2 mediates chemoresistance in matched pairs of primary E(mu)-myc lymphomas in vivo.
    Schmitt CA, Lowe SW.
    Blood Cells Mol Dis; 2001 Mar 14; 27(1):206-16. PubMed ID: 11358381
    [Abstract] [Full Text] [Related]

  • 17. Role of bcl-X(L) in the control of apoptosis in murine myeloma cells.
    Gauthier ER, Piché L, Lemieux G, Lemieux R.
    Cancer Res; 1996 Mar 15; 56(6):1451-6. PubMed ID: 8640839
    [Abstract] [Full Text] [Related]

  • 18. Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis.
    Conner EA, Lemmer ER, Omori M, Wirth PJ, Factor VM, Thorgeirsson SS.
    Oncogene; 2000 Oct 19; 19(44):5054-62. PubMed ID: 11042693
    [Abstract] [Full Text] [Related]

  • 19. Role for Bcl-xL in the regulation of apoptosis by EGF and TGF beta 1 in c-myc overexpressing mammary epithelial cells.
    Nass SJ, Li M, Amundadottir LT, Furth PA, Dickson RB.
    Biochem Biophys Res Commun; 1996 Oct 03; 227(1):248-56. PubMed ID: 8858133
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.